Valuation Vector Science and Therapeutics Corp.
Stocks
PAIN
CA92244M1041
Investment Holding Companies
|
Delayed
Toronto S.E.
15:59:55 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 2.110 CAD | +10.47% |
|
+5.50% | +4,120.00% |
| 08-24 | Vector Science Starts Manufacturing Pharma-Grade Peptides | MT |
| 08-24 | Vector Science & Therapeutics Increases Peptide Manufacturing Capacity At Lyogenesis Facility | CI |
Company Valuation: Vector Science and Therapeutics Corp.
Data adjusted to current consolidation scope
| Fiscal Period: August | 2025 |
|---|---|
| Market Cap 1 | 0.1109 |
| Change | - |
| Enterprise Value (EV) 1 | -2.771 |
| Change | - |
| P/E | -0.29x |
| PBR | 0.15x |
| PEG | - |
| Capitalization / Revenue | - |
| EV / Revenue | - |
| EV / EBITDA | - |
| EV / EBIT | 6.06x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | -0.1292 |
| Distribution rate | - |
| Net sales | - |
| EBITDA | - |
| EBIT 1 | -0.4571 |
| Net income 1 | -0.898 |
| Net Debt 1 | -2.882 |
| Reference price 2 | 0.037 |
| Nbr of stocks (in thousands) | 3,000 |
| Announcement Date | 4/14/26 |
1USD in Million2USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PAIN Stock
- Valuation Vector Science and Therapeutics Corp.
Select your edition
All financial news and data tailored to specific country editions
